Skip to main content
Sangamo Therapeutics, Inc. (SGMO)
NASDAQ: SGMO · Real-Time Price · USD
0.781
-0.012 (-1.45%)
At close: Oct 4, 2024, 4:00 PM
0.785
+0.004 (0.51%)
After-hours: Oct 4, 2024, 7:33 PM EDT

Sangamo Therapeutics Revenue

Sangamo Therapeutics had revenue of $356.00K in the quarter ending June 30, 2024, a decrease of -94.79%. This brings the company's revenue in the last twelve months to $12.28M, down -94.38% year-over-year. In the year 2023, Sangamo Therapeutics had annual revenue of $176.23M with 58.34% growth.

Revenue (ttm)
$12.28M
Revenue Growth
-94.38%
P/S Ratio
11.82
Revenue / Employee
$30,314
Employees
405
Market Cap
162.62M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023176.23M64.93M58.34%
Dec 31, 2022111.30M598.00K0.54%
Dec 31, 2021110.70M-7.49M-6.34%
Dec 31, 2020118.19M15.76M15.39%
Dec 31, 2019102.43M17.98M21.29%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
TruBridge 336.56M
biote 187.23M
Lifecore Biomedical 128.44M
The Joint 120.07M
Semler Scientific 61.74M
Compugen 42.72M
Stereotaxis 23.75M
Generation Bio Co. 13.17M
Revenue Rankings

SGMO News

More News